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STATE-OF-THE-ART PAPER STATE-OF-THE-ART PAPER2145Diuretics and Ultrafiltration in Acute Decompensated Heart FailureG. Michael Felker, Robert J. Mentz
Congestion and volume overload are the hallmarks of acute decompensated heart failure, and
loop diuretics have historically been the cornerstone of treatment. However, the use of loop
diuretics is also associated with neurohormonal activation, diuretic resistance, and the risk of
acute kidney injury. Felker and Mentz review the pathophysiology and recently published
clinical trials of both diuretics and peripheral veno-venous ultrafiltration as alternative
strategies to manage volume overload and identify challenges and unresolved questions for
each approach.VIEWPOINT AND COMMENTARY VIEWPOINT AND COMMENTARYA Policy for Science2154Michael S. Lauer
2157David R. Holmes Jr
Lauer, the Director of the Division of Cardiovascular Sciences at the National Heart, Lung,
and Blood Institute (NHLBI) describes his vision of a Policy for Science in a Viewpoint
paper. He notes that typically, ideally, policymakers should look to scientists for advice, but
too often the opposite occurs: people outside science develop policies that affect the conduct
of science. He uses the debate about coverage for computed tomography angiography to
illustrate a “policy for science,” in which stakeholders would band together to identify
evidence gaps and use their influence to promote the efficient design, implementation, and
completion of high-quality trials. Holmes, in an accompanying commentary, points out some
of the difficulties in requiring randomized trial data as the basis for all clinical decisions.(continued on page A-26)
JUNE 12, 2012 (continued) A-26CLINICAL RESEARCH INTERVENTIONAL CARDIOLOGY
2159A Randomized Trial of Prasugrel Versus Clopidogrel
in Patients With High Platelet Reactivity on ClopidogrelDietmar Trenk, Gregg W. Stone, Meinrad Gawaz, Adnan Kastrati, Dominick J. Angiolillo, Ulrike Müller,
Gert Richardt, Joseph A. Jakubowski, Franz-Josef Neumann
The TRIGGER-PCI trial investigated the efficacy, safety, and antiplatelet effect of prasugrel
as compared with clopidogrel in patients with high on-treatment platelet reactivity (HTPR).
Patients undergoing elective percutaneous coronary intervention (PCI) with HTPR after pre-
loading with 600 mg of clopidogrel were randomly assigned to prasugrel or clopidogrel.
Platelet reactivy decreased at 3 months with prasugrel, but did not change in those assigned to
clopidogrel. The primary efficacy endpoint of cardiac death or myocardial infarction at 6 months
occurred in no patients on prasugrel and only 1 patient on clopidogrel and there was also no
difference in TIMI major bleeding. Switching from clopidogrel to prasugrel improved HTPR, but
given the low rate of adverse ischemic events, the clinical utility of this strategy is unclear.INTERVENTIONAL CARDIOLOGY2165Residual SYNTAX Score Quantifies Risk of Death After PCIPhilippe Généreux, Tullio Palmerini, Adriano Caixeta, Gregg Rosner, Philip Green, Ovidiu Dressler,
Ke Xu, Helen Parise, Roxana Mehran, Patrick W. Serruys, Gregg W. Stone
Incomplete revascularization (IR) after percutaneous coronary intervention (PCI) is common,
and appears to be associated with worse prognosis compared to complete revascularization
(CR). Généreux and colleagues used the SYNTAX scoring methodology to formally quantify
the extent and complexity of residual atherosclerosis after PCI. The baseline SYNTAX score
(bSS) from patients undergoing PCI in the ACUITY trial was determined as was the
SYNTAX score after PCI which was termed the “residual” SS (rSS). Following PCI, 40% of
patients had an rSS of 0 (CR). By multivariable analysis, rSS was a strong independent
predictor of all ischemic outcomes at 1 year, including all-cause mortality. The rSS is useful
to quantify and risk-stratify the degree and complexity of residual stenosis after PCI.INTERVENTIONAL CARDIOLOGY
2175Post-Conditioning Reduces Infarct Size
and Myocardial Edema in Patients With STEMIFranck Thuny, Olivier Lairez, François Roubille, Nathan Mewton, Gilles Rioufol, Catherine Sportouch,
Ingrid Sanchez, Cyrille Bergerot, Hélène Thibault, Thien Tri Cung, Gérard Finet, Laurent Argaud,
Didier Revel, Geneviève Derumeaux, Eric Bonnefoy-Cudraz, Meier Elbaz, Christophe Piot, Michel Ovize,
Pierre Croisille
Thuny and colleagues sought to determine whether post-conditioning as part of the primary
percutaneous coronary intervention procedure could reduce reperfusion-induced myocardial
edema in patients with acute ST-segment elevation myocardial infarction (STEMI). A total
50 STEMI patients were randomly assigned to either control or post-conditioning. The
post-conditioning group underwent 4 cycles of balloon occlusion and deflation for 1 min
immediately after stent placement. Post-conditioning was associated with smaller infarct size
and peak creatine kinase serum level. The extent of myocardial edema detected by cardiac
magnetic resonance imaging was significantly also significantly reduced. Larger clinical trials
will be needed to determine if this translates into improved clinical outcomes.
(continued on page A-27)
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EHEART RHYTHM DISORDERS2182PDE Inhibitors May Protect Against Atrial ArrhythmiasCristina E. Molina, Jérôme Leroy, Wito Richter, Moses Xie, Colleen Scheitrum, Illkyu-Oliver Lee,
Christoph Maack, Catherine Rucker-Martin, Patrick Donzeau-Gouge, Ignacio Verde, Anna Llach,
Leif Hove-Madsen, Marco Conti, Grégoire Vandecasteele, Rodolphe Fischmeister
Molina and colleagues examined whether phosphodieterase (PDE)-4, a cyclic adenosine
monophosphate (cAMP) phosphodiesterase, is expressed in human atria and contributes to
the control of electrical stability and thus affects the likelihood of developing atrial fibrillation
(AF). L-type Ca2 current (ICa,L) and Ca2 sparks were recorded in isolated human atrial
yocytes (HAMs). The results show that PDE4 is expressed in HAMs, and that PDE4
nhibition increased intracellular cAMP and ICa,L and dramatically delayed their decay
ollowing -adrenergic stimulation. PDE4 activity was found to be lower in patients with
ermanent AF than in sinus rhythm controls. PDE4 is critical in controlling cAMP levels
nd thereby Ca2 influx and release in human atrial muscle, which reduces the susceptibility
o arrhythmias.ditorial Comment: David R. Van Wagoner, Bruce D. Lindsay, page 2191HEART RHYTHM DISORDERS2193Electrophysiologic Remodeling of the LV in Pressure Overload-Induced RV FailureMaxim Hardziyenka, Maria E. Campian, Arie O. Verkerk, Sulaiman Surie, Antoni C. G. van Ginneken,
Sara Hakim, André C. Linnenbank, H. A. C. M. Rianne de Bruin-Bon, Leander Beekman,
Mart N. van der Plas, Carol A. Remme, Toon A. B. van Veen, Paul Bresser, Jacques M. T. de Bakker,
Hanno L. Tan
Hardziyenka and colleagues studied electrophysiologic remodeling of the atrophic left
ventricle (LV) in patients with right ventricular (RV) failure (RVF) due to RV pressure
overload. The initial experiments were in a rat model of RVF and used Langendorff-perfused
hearts, patch-clamp studies, and gene and protein expression measurements after monocrotaline
injection. The LV of rats with RVF had longer action potentials and effective refractory
periods and slower longitudinal conduction velocity, which seemed to be caused by a
reduction in cell length and width. Similar results were seen in humans with RVF due to
chronic thromboembolic pulmonary hypertension. Pressure overload-induced RVF is
associated with electrophysiologic remodeling of the atrophic LV.
Editorial Comment: Henry H. Hsia, Francois Haddad, page 2203(continued on page A-28)
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Caroline M. Nievergelt, Michael G. Ziegler, Daniel T. O’Connor
Davis and colleagues used a cross-sectional, twin-study design to probe the role of heredity in
the autonomic and hemodynamic disturbances that lead to pre-hypertension. A total of 812
subjects underwent noninvasive hemodynamic, autonomic, and biochemical testing. The
hemodynamic findings suggest that increased cardiac contractility (LV dP/dT max) elevated
blood pressure (BP) into the pre-hypertension range, while autonomic measurements detected
increased norepinephrine secretion plus a decline in cardiac parasympathetic tone. Twin pair
variance assessments showed substantial heritability for BP and the contributory autonomic
and hemodynamic traits. Pre-hypertension may result from both diminished parasympathetic
and increased sympathetic tone, traits which display substantial heritability and shared genetic
determination by loci not yet fully elucidated.
